Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." POTTER-10

Trial Profile

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." POTTER-10

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Jul 2018

At a glance

  • Drugs Octocog alfa (Primary)
  • Indications Haemophilia A
  • Focus Therapeutic Use
  • Acronyms POTTER 10
  • Sponsors Bayer
  • Most Recent Events

    • 22 Jun 2018 Planned End Date changed from 18 May 2018 to 20 Jul 2018.
    • 02 May 2018 Planned End Date changed from 13 Apr 2018 to 18 May 2018.
    • 02 Apr 2018 Planned End Date changed from 20 Mar 2018 to 13 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top